Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/8/2025 | $16.00 → $20.00 | Outperform | RBC Capital Mkts |
| 4/16/2025 | $25.00 | Outperform | Mizuho |
| 2/24/2025 | $23.00 | Hold → Buy | The Benchmark Company |
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
| 1/18/2022 | $40.00 → $35.00 | Buy | B of A Securities |
| 1/18/2022 | $50.00 → $47.00 | Outperform | RBC Capital |
MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and the Philadelphia Eagles have announced a multi-year extension of its longstanding 25-year partnership naming NovaCare Rehabilitation as the team's Official Physical Therapy Partner. "We are proud to continue our longstanding founding partner relationship with the Philadelphia Eagles, an organization that shares our passion for excellence and creating unforgettable fan experiences," said Ray Pennacchia, senior vice president, NovaCare Rehabilitation. "Many of those fans also trust NovaCare Rehabilitation for world-class physical therapy throughout the Delaware Valley. This renewed agreement bui
MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call
MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listen
RBC Capital Mkts reiterated coverage of Select Medical with a rating of Outperform and set a new price target of $20.00 from $16.00 previously
Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00
The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
3 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
SCHEDULE 13D - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call
MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listen
MECHANICSBURG, Pa., Oct. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, October 31, 2025, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For l
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer. David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board. John A. Saich, who most recently held the position of co-president, will serve as the company's sole president. John F. Duggan has been appointed executive vice president, general counsel and secretary. The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi